Free Trial

Is the January Effect reliable indicator for yearly performance?

January effect stocks

Key Points

  • The January Effect, or January Barometer, suggests January returns can predict full-year market outcomes.
  • Since 1950, the January Barometer has been wrong only 11 times.
  • January also tends to be a month with positive returns, but that doesn't mean the year will finish to the upside. 
  • MarketBeat previews the top five stocks to own by March 1st.

The S&P 500 and other major indexes are getting off to a slow start to kick off the new year. Some of 2023’s leading stocks including Tesla Inc. NASDAQ: TSLA, Norwegian Cruise Line Holdings Ltd. NYSE: NCLH, Micron Technology Inc. NASDAQ: MU, Apple Inc. NASDAQ: AAPL and Meta Platforms Inc. NASDAQ: META were trading sharply lower, along with the broader SPDR S&P 500 ETF Trust NYSEARCA: SPY

Does that mean the January Effect, also known as the January Barometer, is signaling something about the month’s and year’s performance?

The January Effect in stocks is a phenomenon that refers to a historical pattern in which January’s return is predictive of the full year’s return. 

But is it significant? Is January's stock market performance truly an indicator of how the year may go? 

To answer that, let’s step into our time machine go back to 1950 and the formation of the S&P 500’s precursor, the Composite Index. 

January Barometer: Track record of accuracy

Since 1950, the January Barometer has been wrong only 11 times, all the way through 2023. That’s an accuracy rate of about 85%. 

But if we dig a little deeper, we’ll see that between 1950 and 2023, the S&P 500 was up 54 years, which equates to a positive annual return 74% of the time.

That means the January effect may simply be related to the overall tendency of the S&P 500 to show a positive return in nearly three-quarters of years, regardless of what happens in January. 

As investors, and frankly, as humans, we like to think there’s something special about the month. 

It's taxes, not fortune-telling

In fact, there may be, but not in some kind of fortune-telling way. Instead, it’s related to something as mundane as taxes. 

According to an August 2023 blog post from American Century Investments, “The 'January Effect' and Stock Market Seasonality,” the January Effect refers back to a tendency for the market to show gains in the first month of the year.

In recent years, said American Century, “tax-loss harvesting is the most frequent cause cited for the January Effect. After selling some of their stocks at year-end for tax purposes, investors reenter the market in January.”

Tax-loss harvesting is a strategy in which investors sell stocks with a loss. Those losses can be used to offset capital gains. That reduces an investor’s taxable income, which lowers tax liability. 

Swapping out the losers

The investor may then reinvest the proceeds of the sale in a similar, but not identical, asset to maintain market exposure to a desired industry. For example, Pfizer Inc. NYSE: PFE ended 2023 with a loss, although investors can sell a stock and claim the loss any time of year. It’s not necessary to wait until December, although that’s what many investors do.

So imagine an investor who sold Pfizer for a loss but still wants exposure to pharmaceutical stocks. That person can turn around and take the proceeds from Pfizer and put the money into Novo Nordisk A/S NYSE: NVO, which has been flying high on the strength of obesity drugs Wegovy and Ozempic. 

You can see the results of that trade, or similar ones, especially if big institutional investors are selling losers and piling into stocks with more potential. If investors do some portfolio housecleaning as the year winds down, they have cash on hand in January, resulting in greater inflows with the potential to send stocks higher. 

“Similarly, investors re-engaging in the market and rebalancing portfolios after the holiday season may be another source for bullish January behavior,” said American Century.

Not a reliable indicator

However, American Century also pointed out that the January effect has diminished over the years, and should not be considered a reliable investing strategy. 

In addition, it turns out there’s no similar effect with non-U.S. stock indexes, and the January Effect has been diminishing in U.S. small caps. That suggests some kind of anomaly that may have been present in the S&P 500 for some period of time, but whose reliability is waning.

Ultimately, while January's performance may be an indicator of how the year will go, it’s not something you can peg any kind of investing strategy on. Better to simply track your investments, rebalance as needed, use strategies like tax-loss harvesting to your advantage and make sure your investments are lined up with your risk tolerance, financial goals and time horizon. 

Should You Invest $1,000 in Apple Right Now?

Before you consider Apple, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Apple wasn't on the list.

While Apple currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Kate Stalter
About The Author

Kate Stalter

Contributing Author

Retirement, Asset Allocation, and Tax Strategies

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Apple (AAPL)
4.7821 of 5 stars
$247.10+0.6%0.40%39.22Moderate Buy$244.85
Micron Technology (MU)
4.9404 of 5 stars
$95.41-3.5%0.48%27.50Moderate Buy$134.96
Norwegian Cruise Line (NCLH)
4.7997 of 5 stars
$24.86+3.1%N/A22.81Moderate Buy$29.00
Novo Nordisk A/S (NVO)
4.4758 of 5 stars
$90.58+2.8%0.79%27.53Moderate Buy$145.25
Pfizer (PFE)
4.9993 of 5 stars
$26.67+1.4%6.45%18.92Moderate Buy$31.92
Tesla (TSLA)
4.5862 of 5 stars
$330.53-2.2%N/A162.03Hold$319.57
Micron Technology (MU)
4.9404 of 5 stars
$95.41-3.5%0.48%27.50Moderate Buy$134.96
Meta Platforms (META)
3.7364 of 5 stars
$668.13-2.3%0.31%27.93Moderate Buy$719.26
SPDR S&P 500 ETF Trust (SPY)N/A$597.21-0.5%1.18%N/AModerate Buy$597.21
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

These Are the 3 Stocks Most Likely to SPLIT in 2025
NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines